mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.02 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.03 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.03 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.03 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.03 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.03 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |